The COVID-19 pandemic has disproportionately impacted immunocompromised patients.
This diverse group is at increased risk for impaired vaccine responses, progression to …

Background A significant increased risk of complications and mortality in
immunocompromised patients affected by COVID-19 has been described. However, the …

Nirmatrelvir/ritonavir (NR) use has not yet been described in solid organ transplant
recipients (SOTRs) with mild COVID‐19. The objective was to evaluate outcomes among …

Background The effect of solid organ transplantation (SOT) on the severity and mortality of
coronavirus disease 2019 (COVID-19) remained controversial. There is still no consensus …

Background The COVID-19 pandemic has a great impact on solid organ transplant (SOT)
recipients due to their comorbidities and their maintenance immunosuppression. So far …

Since its outbreak in December 2019, the coronavirus disease 2019 (COVID-19) pandemic,
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), led to an …

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection can progress to a
severe respiratory and systemic disease named coronavirus disease–2019 (COVID-19) …

Hypothalamic neuropeptides named hypocretin/orexins which were identified in 1998
regulate critical functions such as wakefulness in the central nervous system. These past 20 …

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) arose in December 2019
in China rapidly evolving to the Coronavirus Disease 2019 (COVID-19) pandemic. Since …

Background The COVID‐19 pandemic has caused significant morbidity and mortality in solid
organ transplant (SOT) recipients. However, it remains unclear whether the risk factor for …